| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:280-286.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Public Health and Medical Information, Nice Teaching Hospital, and the Department of Cardiology, Nice Teaching Hospital (P.G.), Nice, France.
Correspondence to Dr Fabrice Boulay, Département d'Information Médicale, CHU de Nice BP 1179, 06003 Nice Cedex 1, France. E-mail boulayf{at}hotmail.com
| Abstract |
|---|
|
|
|---|
Methods and ResultsAll deaths that occurred among French adults
over the period 1992 to 1996 (n=138 602) and all discharges by adults
in French public hospitals for chronic heart failure over the period
1995 to 1997 (n=324 013) were examined retrospectively. First, chronic
heart failure deaths in France occurred with a striking annual
periodicity and peaked in winter (December through January), both in
the overall population and in subgroups defined by age (>44 years old)
and sex. The distribution of cumulative monthly deaths differed by
nearly 35%, ranging from a peak of 20% above average in January to
15% below average in August (Roger's test: P<0.001).
Second, hospitalizations for chronic heart failure in French public
hospitals followed a similar seasonal pattern
(P<0.001), with a winter-spring predominance (+7% to
+10% from December through April). Third, for persons
85 years old,
excess hospitalizations occurred earlier in the year, with marked
synchronized peaks in January for both mortality and hospitalizations
(P<0.001).
ConclusionsClear seasonal variations in adult chronic heart failure hospitalizations and deaths were identified. The considerable economic impact on health care services warrants further epidemiological investigations and a more comprehensive approach to disease management.
Key Words: heart failure seasons mortality
| Introduction |
|---|
|
|
|---|
In contrast to these favorable trends for most cardiovascular conditions, the incidence and prevalence of chronic heart failure and the resulting mortality and morbidity have increased dramatically during the period 1980 to 1988.3 This disabling chronic disease may increase further with the increasing proportion of the elderly within the population,4 the expected prolonged survival of patients with coronary heart disease and hypertension given prompt thrombolytic therapy,5 the widespread use of revascularization,6 and the improvements achieved in hypertension treatment.7
A considerable amount of data indicates that circadian rhythms are observed in acute myocardial infarction, sudden cardiac death, thrombotic stroke, and transient myocardial ischemia.8 9 10 11 Circannual variation in blood pressure and in the incidence of acute myocardial infarction is well known12 13 but has not been investigated in chronic heart failure.
This report aimed to describe and compare seasonal variation in chronic heart failure hospitalizations and mortality, using 2 population-based information systems, the French Cause-of-Death Statistics (from the Institut National de la Santé et de la Recherche Médicale, INSERM) and the National Hospital Discharge Register (NHDR).
| Methods |
|---|
|
|
|---|
15 years old were examined retrospectively.
Hospitalization Data
Information on hospitalizations was obtained from the Centre de
Traitement de l'Information du PMSI, an official organization of the
French Ministry of Health. This data set is a national collection of
all discharges from public and nonprofit short-stay/acute-care
hospitals. These hospitals have 188 960 short-stay/acute-care beds,
accounting for
71% of the hospital capacity in France in 1996.
The NHDR information is abstracted by physicians from information found in the patient's medical record. This information includes age, sex, month of discharge, discharge status, space for up to 99 medical diagnoses and 99 procedures, and geographic location. Medical diagnoses were classified according to the International Classification of Diseases, Ninth Revision (ICD9) until 1996 and Tenth Revision (ICD10) in 1997 and thereafter.
Mortality Data
Data on chronic heart failure mortality were obtained from the
French Cause-of-Deaths Statistics system. Each year, >530 000 death
certificates are filled out, providing information on the decedent's
medical diseases, demographic characteristics, date and place of death,
and performance of an autopsy. For each death, the underlying
cause of death and other significant conditions are indicated.
Beginning in 1968, the Cause-of-Death Statistics published by INSERM
have been classified according to ICD9.
Mortality rates were calculated and adjusted by use of 1990 annual population estimates by age and sex, from the Institut National des Statistiques et des Etudes Economiques.
In addition, we compared the number of deaths enumerated from the NHDR with the number of deaths recorded on the national INSERM mortality statistics.
Case Definition
Both chronic heart failure mortality and hospitalizations were
based on the 3-digit ICD9 code 428 and ICD10 code I50. The
number of deaths is reported from counts of underlying cause of death.
Hospitalizations are reported from the first listed discharge
diagnosis.
Statistical Considerations
The data collected in this report are not subject to sampling
error because hospitalizations and mortality data were obtained from
the full set of hospital discharges and death certificates for the
study period. These data are subject to random variation and are
presented as mean and SD.
Both hospitalizations and mortality data were plotted according to 2 different graphic representations. First, for the purpose of smoothing the data, we used a moving average to present complete 3-year monthly data for chronic heart failure hospitalizations and 5-year monthly data for chronic heart failure mortality. For these plots, each data point (except first and last months) represents an average of 3 months' data: the current month and both the preceding and following months. Second, we presented 3 years and 5 years of combined data, respectively, as a percentage above or below the average monthly value for the entire study period, the sum of monthly variations being 0.
Total seasonal variations were measured as the sum of the percentage above the mean for the month with the highest value and the percentage below the mean for the month with the lowest value.
The statistical analysis of seasonal variations was based on Roger's method, which identifies a higher frequency of cases at a consistent period of the year.14 P values of <0.05 were considered significant.
| Results |
|---|
|
|
|---|
85 years old (Table 1
|
Overall Population
During the 2 periods, death certificate data showed an average of
2310±287 (SD) deaths per month, and public hospital discharge data
showed 9000±1315 discharges per month and 944±155 in-hospital deaths
per month. Figure 1
, which plots the
monthly moving average of mortality, hospitalizations, and in-hospital
deaths, shows a striking annual periodicity (P<0.001).
|
The distribution of cumulative monthly deaths showed a marked winter
predominance (Figure 2
, Table 2
). Average monthly deaths for chronic
heart failure differed by
35% throughout the year, ranging from a
peak of 20% above average in January to 15% below average in
August.
|
|
The distribution of cumulative monthly hospitalizations was slightly
different and showed a winter-spring predominance (Figure 2
and
Table 2
). Average monthly admissions for chronic heart failure
differed by
30%, ranging from 10% above average in April to 20%
below average in August.
The seasonal variations in total mortality for chronic heart failure
and mortality in French public hospitals for chronic heart failure are
compared in Figure 3
. Deaths occurring in
public hospitals followed the same seasonal pattern with a more marked
January peak (+28% versus +20%).
|
Subgroups
The same winter predominance of cumulative monthly deaths was
observed in subgroups defined by age and sex except for individuals 15
through 44 years old (Table 2
). Monthly chronic heart failure
deaths for the oldest age group (
85 years old) differed by as much as
43% (the largest total seasonal variation), ranging from a peak of
26% above average in January to 17% below average in August (Figure 4
). The pattern for other age groups
demonstrated lower amplitude (total seasonal variation ranging from
32% to 34%), with a peak mortality in December.
|
As seen in Table 2
, a nonsignificant pattern of mortality
(P>0.50) was observed within the population 15 through 44
years old (n=683 for 5 years, 0.5% of total deaths) with a second peak
in summer (+16% above average in August). Other groups defined by age
and sex demonstrated highly significant seasonal variations
(P<0.001), except for individuals 45 through 64 years old
(P<0.01).
The distribution of cumulative monthly hospitalizations demonstrated
some differences by subgroups defined by age and sex (Table 2
).
Hospitalization peaks were seen in January for persons >75 years old
and in April for those 15 to 74 years old. A similar difference in the
timing of the peak was found for the sex subgroups, but this difference
could be attributed entirely to the older age of the female subjects.
In subgroups defined by age and sex, the distribution of cumulative
monthly hospitalizations showed a highly significant seasonal variation
(P<0.001), except for individuals 15 through 44 years old
(P<0.01).
For individuals
85 years old, the mortality and hospitalization
curves were almost the same, with marked synchronized peaks in January
(Figure 4
).
| Discussion |
|---|
|
|
|---|
85 years old, the rise
in hospitalizations began earlier in the season, with both mortality
and hospitalizations exhibiting the same marked synchronized peak in
January.
Previous Studies
The only mention of seasonality with regard to chronic heart
failure found in the literature is a report by Parry et
al15 from northern Nigeria, who noted that patients with
chronic heart failure presented more frequently during the hot
wet months than during the cooler dry months. This author reported a
limited series (753 patients over a 3-year period) who had cardiac
failure mainly in the peripartum period (40.6%).
Present Study
Average annual mortality in France (47.5 deaths per 100 000)
differs from rates reported in the literature. It is well known that
reliability and comparability of mortality and morbidity statistics are
significantly limited by variations in data collection and coding and
by differences in the approach to diagnosis of
cardiovascular diseases within and between countries
and over time.16
One example of differences due to data collection is shown by the 236.5 per 100 000 rate reported for Spain for 1993.17 In this study, heart failure deaths were counted from several codes of the ICD9, including code 425 (cardiomyopathy), code 428 (chronic heart failure), and code 429 (ill-defined descriptions and complications of heart disease).
Differences in the approach to diagnosis or certification are illustrated by the latest rates available for the United States, where 11.7 deaths per 100 000 inhabitants are reported for 1995.3 Mortality figures usually underestimate the demographic impact of chronic heart failure, because they include chronic heart failure only when it is the underlying cause of death. In the United States, chronic heart failure is 5 to 6 times more likely to be reported as a contributor rather than as the underlying cause of death on the death certificate.3 In France, death certificates are filled out somewhat differently than in the United States. For 1994, for example, chronic heart failure was mentioned as the primary cause of death on 26 783 certificates and as the first contributive cause in only 9023 cases.18 In the United Kingdom, the death certificate explicitly forbids chronic heart failure to be entered as the primary cause of death, and instead the underlying pathological process is specified, eg, coronary heart disease.19
Potential Mechanisms Underlying Seasonal Pattern
Chronic heart failure is a syndrome that develops as a consequence
of many different processes that impair cardiac function.
Coronary heart disease and hypertension (either singly or
together) account for the vast majority of cases of chronic heart
failure within the developed world. Several authors have reported a
predominantly winter pattern for blood pressure12 20 and
myocardial infarction.13
Several studies have searched for factors that could trigger acute exacerbations of chronic heart failure. The factors most frequently cited included fluid-sodium burden, acute episodes of arrhythmia, and poor patient compliance. The infectious factor is also cited, with a frequency in the range of 10% to 20%, depending on the report.21 22 In addition to the well-known seasonal pattern of infectious diseases, particularly respiratory tract infections,23 acute arrhythmia has also been found to follow seasonal variations.24 25
Many investigators have documented an increase in respiratory and cardiovascular morbidity and mortality during winter, especially during cold weather.26 27 The winter excess of cardiovascular mortality has been linked to physiological responses to low temperatures, in which the sympathetic nervous system appears to play an important role.
Izzo et al28 studied seasonal changes in hemodynamics and found increases in heart rate and total peripheral resistance but a decrease in cardiac output in winter. Their results suggest that a cold climate causes sympathetically mediated vasoconstriction, which leads to an elevation of afterload. Peripheral vasoconstriction induced by the cold may cause acute pulmonary edema by overloading the left ventricle, in particular, in those predisposed to hypertension.29
Another mechanism is the modification of total extracellular volume. When the temperature decreases, loss of water by transpiration and perspiration decreases. Because these may be more important mechanisms of water loss than urine output in patients with renal disease and chronic heart failure, variations in transpiration and perspiration may influence extracellular volume homeostasis in these patients more than in normal subjects.20
It is also possible that this seasonal variation in cardiovascular function is related to factors other than temperature that change with the season. Yearly variations in cardiovascular function are probably mediated by genetically fixed endogenous rhythms in relation to neuroendocrine and/or metabolic function. A seasonal variation in thyroid and adrenal function and in the function of the sympathetic nervous system has been reported.30 31 Exogenous seasonal effects such as daytime length may affect the endogenous rhythm, altering the shape and timing of seasonal variation.32 The known winter increase in caloric intake may result in an increase in sodium intake.30 Variations in factors such as atmospheric pollution, other climatic factors (atmospheric pressure or rainfall/sun exposure), and use of drugs may also be involved.
In the subgroup of persons
85 years old, the mortality and
hospitalization curves were almost the same, with marked synchronized
peaks in January. Several explanations can be put forward. First, these
individuals could have more advanced-stage heart failure more easily
aggravated by winter-related triggering factors. Second, these older
individuals could be more susceptible to respiratory tract infections.
Third, seasonal variations in hemodynamic conditions
(afterload) could be more marked in the elderly. It is noteworthy that
the seasonal variation in blood pressure appears to be larger in older
than in younger subjects.12 33
Study Limitations
In addition to the fact that there is no universally accepted
definition of chronic heart failure, the retrospective nature of this
type of study raises the question of the quality of the mortality and
hospital discharge data. There is no reason, however, to believe that
any of these limitations have a systematic seasonal element.
Another potential limitation is that our databases do not collect information on all pulmonary and cardiovascular risk factors or possible precipitating factors for relationship between season and chronic heart failure. Because of the well-known underreporting of associated diagnosis, we limited ourselves to the primary cause of death and the primary hospital diagnosis, ignoring various etiological factors.
Because hospital records and death certificates carry an inherent bias toward sicker, hospitalized persons, our results concerned patients who had more advanced-stage chronic heart failure.
Caution must be exercised in the interpretation of hospitalization data. These data, unlike the mortality information, describe episodes of care. Any given individual may experience several episodes of hospital care. Therefore, hospitalization data are not person-based. Also, the hospitalization data do not reflect information on outpatient department use, a much more frequent source of care of mild to moderate chronic heart failure.
However, the fact that similar patterns occurred in different subgroups and appeared in both mortality and hospitalization data would enhance the credibility of these statistics. In addition, the nationwide nature of these large databases limits certain selection biases related to seasonal population variations. Mandatory quality control checks are performed every 6 months by the Medical Information Department of each hospital and every year by physicians from the governmental authorities and the national health insurance system.
The circannual periodicity of chronic heart failure deaths and hospitalizations clearly demonstrated by these epidemiological data, showing a peak incidence in winter months, has important clinical implications. Healthcare systems should adjust the availability of emergency services and other hospital resources to the circannual pattern. Susceptible patients should be informed of the increased risk during winter. These data also offer a means of better understanding the fundamental pathophysiological mechanisms underlying exacerbation of chronic heart failure and could be useful for practitioners to improve causative prevention measures, therapeutic management, and educational strategies.
| Acknowledgments |
|---|
Received February 2, 1999; revision received April 19, 1999; accepted April 22, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S.-Y. Li, J.-Y. Chen, C.-L. Chuang, and T.-W. Chen Seasonal variations in serum sodium levels and other biochemical parameters among peritoneal dialysis patients Nephrol. Dial. Transplant., February 1, 2008; 23(2): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Tseng, M. Brimacombe, M. Xie, M. Rajan, H. Wang, J. Kolassa, S. Crystal, T.-C. Chen, L. Pogach, and M. Safford Seasonal Patterns in Monthly Hemoglobin A1c Values Am. J. Epidemiol., March 15, 2005; 161(6): 565 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
W K. Poole, J. S Chi, J D. Walton, S. Kandefer, and R. A Kloner Increased cardiovascular mortality associated with the turn of the millennium in Los Angeles County, California J. Epidemiol. Community Health, March 1, 2005; 59(3): 205 - 206. [Full Text] [PDF] |
||||
![]() |
D Ehrmann Feldman, R Platt, V Dery, C Kapetanakis, D Lamontagne, A Ducharme, N Giannetti, M Frenette, and E J Beck Seasonal congestive heart failure mortality and hospitalisation trends, Quebec 1990-1998 J. Epidemiol. Community Health, February 1, 2004; 58(2): 129 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Liu, Y.-H. Li, W.-C. Tsai, T.-H. Chao, L.-M. Tsai, H.-L. Wu, and J.-H. Chen Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention Eur. Heart J., October 2, 2003; 24(20): 1824 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cheung, G. Yan, T. Greene, J. T. Daugirdas, J. T. Dwyer, N. W. Levin, D. B. Ornt, G. Schulman, and G. Eknoyan Seasonal Variations in Clinical and Laboratory Variables among Chronic Hemodialysis Patients J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2345 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zannad Have we jugulated the epidemic of heart failure? One swallow does not make a summer . . . Eur. Heart J., February 1, 2001; 22(3): 188 - 190. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |